Repairing longitudinal meniscus tears using fibrin clots

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness of fibrin clot-augmented meniscal repair compared to standard meniscal repair for patients with longitudinal meniscus tears. Participants aged 18 to 50 will be randomly assigned to receive either the fibrin clot-enhanced repair or conventional repair techniques. The fibrin clot will be prepared from bone marrow aspirate and used to reinforce the meniscal repair. Patients will be followed for at least one year post-surgery to assess healing rates through MRI evaluations.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Presenting with a painful meniscus (lateral or medial) longitudinal tear
* Being between the ages of 18 and 50
* Not having undergone surgery on the same knee before
* Having an MRI taken at the end of the 1st year post-surgery

Exclusion Criteria:

* Having additional collateral ligamentous damage along with the meniscus tear (such as MCL or LCL)
* Incomplete clinical scores at the end of the study
* A history of previous surgery on the same knee
* Having an active infection
* Not having a control MRI at the end of the 1st year

Where it's running

• Ankara Bilkent City Hospital
  Ankara, Turkey (Türkiye) Recruiting
• Ankara Etlik City Hospital
  Ankara, Turkey (Türkiye) Recruiting

Study contacts

• Principal investigator: Enejd Veizi, MD — Ankara City Hospital Bilkent
• Study coordinator: Enejd Veizi, MD
• Email: dr.nad89@hotmail.com
• Phone: +905439799959

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Assessment of meniscal root tears treated with suture to the posterior cruciate ligament

  This study tests a new surgical method for fixing meniscal root tears in the knee to see if it helps patients recover better and avoid future problems like arthritis.

  Recruiting Istituto Ortopedico Rizzoli · Bologna · NCT06507241

• Treatment for Posteromedial Tibiofemoral Incongruence

  This study is testing a new knee surgery to see if it can help people with Posteromedial Tibiofemoral Incongruence feel less pain and move better.

  Recruiting Artromedical Konrad Malinowski Clinic · Bełchatów, Łódź Voivodeship · NCT05882591

• Knee cartilage repair registry data collection

  This registry collects real-world information from adults undergoing knee cartilage repair to see how different procedures perform over time.

  Recruiting at 4 sites Smith & Nephew, Inc. · Parker, Colorado and 5 other locations · NCT07786207

• Kinematic markers of patellar tendinopathy in at-risk athletes using markerless motion capture

  Researchers test whether markerless motion capture during vertical jumps can reveal early knee and body movement markers that distinguish athletes at risk for jumper's knee from healthy athletes.

  Recruiting University Hospital, Montpellier · Montpellier · NCT07406516

• Magic Angle Direction Imaging for ACL tears and meniscus injuries

  This study tries a new low-field MRI technique called Magic Angle Direction Imaging to see if it shows ACL tears and meniscus injuries more clearly in adults scheduled for ligament repair.

  Recruiting at 2 sites Imperial College London · London and 1 other locations · NCT07366619

• Fibrin clot and thrombin changes during pregnancy

  This project will test whether fibrin clot structure and thrombin generation change across pregnancy and whether those changes predict blood-clot or high-blood-pressure complications in pregnant women.

  Recruiting Jagiellonian University · Krakow, Małopolska · NCT07275476

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.